Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Gefen-Weihs Biomed from Leuven, company number BE1009878975, closed financial year 2025 with a result of € 374,417 after tax. For that financial year Gefen-Weihs Biomed recorded a gross margin of € 492,076 and equity of € 573,308. Compared with financial year 2024, the result moved from € 197,891 to € 374,417. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 18, 2026.
€ 573,308
▲ 188% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 374,417
▲ 89% vs 2024
Profit after tax over the fiscal year.
€ 33,304
▼ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 572,308.
People and assets in 2025
€ 1,337
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 3
Loans from banks and other lenders, long and short.
€ 117,251
▲ 98% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 256,136 | € 492,076 | ▲ 92% |
| Profit after taxes | € 197,891 | € 374,417 | ▲ 89% |
| Equity | € 198,891 | € 573,308 | ▲ 188% |
| Total debts | € 73,152 | € 132,876 | ▲ 82% |
| Cash | € 38,577 | € 33,304 | ▼ 14% |
| Retained profit | € 197,891 | € 572,308 | ▲ 189% |
| Bank debt | € 0 | € 3 | |
| Balance sheet total | € 272,043 | € 706,183 | ▲ 160% |
By gross margin, Gefen-Weihs Biomed ranks 5th of 37 companies with main activity “Activiteiten van adviesbureaus op het gebied van public relations en communicatie” in Leuven that publish figures (fiscal year 2025).
Key figures of Gefen-Weihs Biomed, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Gefen-Weihs Biomed the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Gefen-Weihs Biomed?
What happened at Gefen-Weihs Biomed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 374,417 (▲ 89% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Leuven. KBO
In short
From € 197,891 profit in 2024 to € 374,417 profit in 2025.
Paid € 178,139 in corporate taxes since 2024.
Best year ever: 2025, with € 374,417 profit.
Management
Behind Gefen-Weihs Biomed are Amit Gefen and Daphne Weihs.
Directors
According to the 2025 annual accounts
Amit Gefen
Director
Daphne Weihs
Director
Establishments
Establishment units
Physical locations of this company
Claire Vellutstraat 12 box 4.01
3000 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Leuven
Same main activity (Activiteiten van adviesbureaus op het gebied van public relations en communicatie), 42 active companies in Leuven, largest first.
€ 6.9 million revenue · 2024
€ 2.7 million gross margin · 2025
€ 855,192 gross margin · 2025
€ 796,346 gross margin · 2025
€ 731,825 gross margin · 2025
€ 404,528 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- GEFEN Amit(oprichter-vennoot) 80%
- WEIHS Daphne(oprichter-vennoot) 20%
Details
- Company number
- 1009.878.975
- VAT number
- BE 1009.878.975
- Registered office
- Claire Vellutstraat 12 bus 4.01, 3000 Leuven
- Names & denominations
- Gefen-Weihs Biomed · GWBiomed
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 May 2024
- Peppol
- Active · Active since 17 Dec 2024
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige onderwijsondersteunende dienstverlening
Overige vormen van onderwijs
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige gespecialiseerde wetenschappelijke en technische activiteiten